Søgeresultater - Jérôme Dauba

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO)

    Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Gr... af Alain Lortholary, R. Largillier, B. Weber, Laurence Gladieff, J. Alexandre, Xavier Durando, B. Slama, Jérôme Dauba, D. Paraïso, Éric Pujade-Lauraine

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Effects of a physical activity programme to prevent physical performance decline in onco‐geriatric patients: a randomized multicentre trial

    Effects of a physical activity programme to prevent physical performance decline in onco‐geriatric patients: a randomized multicentre trial af Haritz Arrieta, Cyril Astrugue, Sophie Regueme, J. Durrieu, Aline Maillard, Alban Rieger, Éric Terrebonne, Alexis Laurent, Brigitte Maget, V. Servent, Sandrine Lavau‐Denès, Jérôme Dauba, Marianne Fonck, Rodolphe Thiébaut, Isabelle Bourdel‐Marchasson

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR)

    Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR) af Jean-François Delattre, Romain Cohen, Julie Henriques, Antoine Falcoz, Jean‐François Emile, Serge Fratté, Benoist Chibaudel, Jérôme Dauba, Olivier Dupuis, Y. Bécouarn, Frédéric Bibeau, Julien Taı̈eb, Christophe Louvet, Déwi Vernerey, Thierry André, Magali Svrcek

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018

    Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018 af Florian Guisier, Catherine Dubos‐Arvis, F. Viñas, H. Doubre, Charles Ricordel, Stanislas Ropert, Henri Janicot, Massimo Bernardi, P. Fournel, R. Lamy, M. Pérol, Jérôme Dauba, Gilles Gonzales, L. Falchero, C. Decroisette, Pascal Assouline, C. Chouaïd, Olivier Bylicki

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer

    Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer af Pierre Soubeyran, Marianne Fonck, C. Blanc-Bisson, Jean‐Frédéric Blanc, J. Ceccaldi, C. Mertens, Y. Imbert, L. Cany, Luc Vogt, Jérôme Dauba, Francis Andriamampionona, Nadine Houédé, Anne Floquet, François Chomy, Véronique Brouste, Alain Ravaud, C. Bellera, M. Rainfray

    Udgivet 2012
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Nutritional Advice in Older Patients at Risk of Malnutrition during Treatment for Chemotherapy: A Two-Year Randomized Controlled Trial

    Nutritional Advice in Older Patients at Risk of Malnutrition during Treatment for Chemotherapy: A Two-Year Randomized Controlled Trial af Isabelle Bourdel‐Marchasson, C. Blanc-Bisson, A. Doussau, Christine Germain, Jean‐Frédéric Blanc, Jérôme Dauba, C. Lahmar, Éric Terrebonne, Cédric Lecaille, J. Ceccaldi, L. Cany, Sandrine Lavau‐Denès, Nadine Houédé, François Chomy, J. Durrieu, Pierre Soubeyran, Pierre Sénesse, Geneviève Chêne, Mariane Fonck

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy

    Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy af Stéphanie Hoppe, M. Rainfray, Marianne Fonck, Laurent Hoppenreys, Jean‐Frédéric Blanc, J. Ceccaldi, C. Mertens, C. Blanc-Bisson, Y. Imbert, L. Cany, Luc Vogt, Jérôme Dauba, Nadine Houédé, C. Bellera, Anne Floquet, Marie-Noëlle Fabry, Alain Ravaud, Camille Chakiba, Simone Mathoulin‐Pélissier, Pierre Soubeyran

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)

    A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1) af Hervé Bonnefoi, Thomas Grellety, Olivier Trédan, Mahasti Saghatchian, Florence Dalenc, Audrey Mailliez, T. L'Haridon, Paul Cottu, Sophie Abadie‐Lacourtoisie, Benoît You, M Mousseau, Jérôme Dauba, Francesco Del Piano, Isabelle Desmoulins, Florence Coussy, Nicolas Madranges, Julien Grenier, François‐Clément Bidard, Charlotte Proudhon, Gaëtan MacGrogan, C. Orsini, M. Pulido, Anthony Gonçalves

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial

    Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial af Jean-Louis Pujol, A. Lavolé, Élisabeth Quoix, Olivier Molinier, P.-J. Souquet, Fabrice Barlési, H. Le Caer, Denis Moro‐Sibilot, P. Fournel, J.P. Oster, Patrick Chatellain, P. Barre, G. Jeannin, Pierre Mourlanette, Marc Derollez, Dominique Herman, Aldo Renault, C. Dayen, Pierre‐Jean Lamy, Alexandra Langlais, Franck Morin, Gérard Zalcman, Virginie Westeel, M. Poudenx, Julien Mazières, Y. Martinet, J-P. Gury, Nathalie Baize, Patrick Dumont, F. Vaylet, Pascal Foucher, Jérôme Dauba, Jean Trédaniel, H. Laize, L. Petit, D. Coëtmeur, H. Doubre, Éric Pichon, S. Schneider, F. Goutorbe, R. Gervais, M. Zaegel, S. Dehette, Bruno Coudert, J-P. Duhamel, A. Dixmier, Luc Thiberville, Philippe Deguiral, H. Monnot, P. Romand, H. Berard, C. Raspaud

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

    Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer af Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon, Imène Chentli, Alexandre Atkinson, Aurore Tranchant, Laurent Castéra, Sophie Krieger, Agathe Ricou, Flavie Boulouard, Florence Joly, Romain Boucly, Aurélie Dumont, Noémie Basset, Florence Coulet, Louise-Marie Chevalier, Étienne Rouleau, Katharina Leitner, Antonio González‐Martín, Piera Gargiulo, Hans‐Joachim Lück, Catherine Genestie, Gerhard Bogner, Christian Marth, Edgar Petru, Alexander Reinthaller, Christian Schauer, P. Sevelda, Lionel D’Hondt, Ignace Vergote, Peter Vuylsteke, Sakari Hietanen, Gabriel Lindahl, Johanna Mäenpää, Trine Jakobi Nøttrup, Ulla Puistola, Sophie Abadie‐Lacourtoisie, Jérôme Alexandre, Émilie Boissier, Hugues Bourgeois, Annick Chevalier-Place, Pierre Judet de La Combe, Cristina Costan, Jérôme Dauba, Laure De Cock, Christophe Desauw, Raymond Despax, Nadine Dohollou, Coraline Dubot, Michel Fabbro, Laure Favier, Anne Floquet, Philippe Follana, Claire Garnier Tixidre, Georges Garnier, Laurence Gladieff, Julien Grenier, Cécile Guillemet, Anne‐Claire Hardy‐Bessard, Florence Joly, Elsa Kalbacher, Marie‐Christine Kaminsky, Jean‐Emmanuel Kurtz, Rémy Largillier, Claudia Lefeuvre‐Plesse, Anne Lesoin, Charles-Briac Levaché, Tifenn L’Haridon, Alain Lortholary, Jean‐Pierre Lotz, Jérôme Meunier, M Mousseau, Marie‐Ange Mouret‐Reynier, Patricia Pautier, Thierry Petit, Magali Provansal, Éric Pujade-Lauraine, Nadia Raban, Isabelle Ray‐Coquard, Manuel Rodrigues, Frédèric Selle, Robert Sverdlin, Youssef Tazi, Benoît You, Bahriye Aktas, Dirk Bauerschlag, Thomas Beck, Antje Belau, Holger Bronger, Stefan Buchholz, Paul Buderath, Alexander Burges, Ulrich Canzler, Nikolaus de Gregorio, Dominik Denschlag, Max Dieterich, Michael Eichbaum, Ayşe Balat, Günter Emons

    Udgivet 2023
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

    Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised... af François‐Clément Bidard, Anne‐Claire Hardy‐Bessard, Florence Dalenc, Thomas Bachelot, Jean‐Yves Pierga, Thibault De La Motte Rouge, Renaud Sabatier, Coraline Dubot, Jean‐Sébastien Frenel, Jean Marc Ferrero, Sylvain Ladoire, Christelle Lévy, Marie‐Ange Mouret‐Reynier, Alain Lortholary, Julien Grenier, Camille Chakiba, Laetitia Stefani, Jérôme Edouard Plaza, Florian Clatot, Luís Teixeira, Véronique D’Hondt, Hélène Vegas, Olfa Derbel, Claire Garnier-Tixidré, Jean-Luc Canon, Barbara Pistilli, Fabrice André, Laurent Arnould, Anne Pradines, Ivan Bièche, Céline Callens, Jérôme Lemonnier, Frédérique Berger, Suzette Delaloge, François‐Clément Bidard, Barbara Pistilli, Florence Dalenc, Thomas Bachelot, Thibault De La Motte Rouge, Renaud Sabatier, Coraline Dubot, Jean‐Sébastien Frenel, Jean-­Marc Ferrero, Sylvain Ladoire, Christelle Lévy, Marie‐Ange Mouret‐Reynier, Anne‐Claire Hardy‐Bessard, Alain Lortholary, Julien Grenier, Camille Chakiba, Laetitia Stefani, P Soulié, Jean-Philippe Jacquin, Jérôme Edouard Plaza, Florian Clatot, Luís Teixeira, Véronique D’Hondt, Hélène Vegas, Olfa Derbel, Claire Garnier Tixidre, Catherine DELBALDO, Lionel MOREAU, Caroline Cheneau, Jean-François Paitel, Chantal BERNARD-MARTY, Dominique Spaeth, Dominique Genet, Isabelle MOULLET, Nathalie BONICHON-LAMICHHANE, Laura DEIANA, Charlotte GREILSAMER, Laurence Venat‐Bouvet, Valérie Delecroix, Adrien MELIS, Hubert Orfeuvre, Suzanne Nguyen, Éric Legouffe, Alain Zannetti, Romuald LE SCODAN, Nadine DOHOLLOU, Philippe DALIVOUST, Olivier Arsene, Nathalie MARQUES, Thierry Petit, Delphine MOLLON, Jérôme DAUBA, Nathalie BONNIN, François MORVAN, Miriam Gardner, Adina MARTI, Charles-Briac Levaché, Emma Lachaier, Mihaela ACHILLE, Christophe VALMAR, Ryan BOUAITA, Jacques Médioni, Cyril FOA, Chantal BERNARD-MARTY, Francesco Del Piano, Michel GOZY

    Udgivet 2022
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  12. 12
    Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

    Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial af Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin, Lisa Belin, Katharina Leitner, David Cibula, Hannelore Denys, Ora Rosengarten, Manuel Rodrigues, Nikolaus de Gregorio, Jerónimo Martínez, Edgar Petru, Roman Kocián, Ignace Vergote, Patricia Pautier, Barbara Schmalfeldt, Lydia Gaba, Stephan Polterauer, Marie‐Ange Mouret‐Reynier, Jalid Sehouli, Cristina Churruca, Frédèric Selle, Florence Joly, Véronique D’Hondt, Émilie Bultot-Boissier, Coriolan Lebreton, Jean‐Pierre Lotz, Rémy Largillier, Pierre-Étienne Heudel, Florian Heitz, Jean‐Emmanuel Kurtz, Sophie Abadie‐Lacourtoisie, Cyril Abdeddaim, J. Alexandre, P. Augereau, D. Avenin, M. Azémar, Nabil Baba-Hamed, Olivia Bally, Jérôme Barrière, Fernando Bazán, Dominique Berton, Nathalie Bonichon-Lamichhane, Nathalie Bonnin, Elouen Boughalem, R. Boustany Grenier, Pierre-Emmanuel Brachet, Fabien Brocard, Émilie Bultot-Boissier, Maria Cappiello-Bataller, Hélène Castanie, L. Chaigneau, Camille Chakiba, Dorothée Chocteau-Bouju, Pierre Combe, Aurélie Comte, Elodie Coquan, Cristina Costan, P. Cottu, L. Crouzet, H. Curé, Jérôme Dauba, Hussain Dawood, Laure De Cock, T. De La Motte Rouge, C. Debelleix, Catherine Delbaldo, Martin Demarchi, Marion Deslandres, Raymond Despax, Véronique D’Hondt, Anne Françoise DILLIES-LEGRAIN, A Donnadieu, C. Dubot, Jean Marc Extra, Michel Fabbro, Claire Falandry, F. Fiteni, Anne Floquet, Philippe Follana, Jean‐Sébastien Frénel, G. Freyer, D. Garbay-Decoopman, C. Gavoille, V. Girre, Laurence Gladieff, F. Goldwasser, Alain Gratet, Jean‐Christophe Grenier, Anne‐Claire Hardy‐Bessard, Pierre-Étienne Heudel, Florence Joly, A. Jouinot, Emilie Kalbacher, Marie‐Christine Kaminsky, Laurence Lancry-Lecomte, R. Largillier, Fanny Le Du, Alexandra Léary, Coriolan Lebreton

    Udgivet 2023
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: